Healthway Medical Corporation Limited reported unaudited group earnings results for the third quarter and nine months ended September 30, 2016. For the quarter, the company reported revenue of SGD 25,486,000 against SGD 23,207,000 a year ago. Profit before income tax was SGD 88,000 against loss of SGD 2,695,000 a year ago. Profit attributable to shareholders was SGD 69,000 against loss of SGD 2,979,000 a year ago. Net cash used in operating activities was SGD 2,071,000 against net cash generated from operating activities of SGD 2,959,000 a year ago. Addition to of property, plant and equipment was SGD 27,000 against SGD 377,000 a year ago. Addition to intangible assets was SGD 2,000.

For the nine months, the company reported revenue of SGD 73,374,000 against SGD 70,945,000 a year ago. Profit before income tax was SGD 714,000 against SGD 3,925,000 a year ago. Profit attributable to shareholders was SGD 704,000 or 0.03 cents per basic and diluted share against SGD 2,587,000 or 0.11 cents per basic and diluted share a year ago. Net cash generated from operating activities was SGD 3,255,000 against SGD 10,736,000 a year ago. Purchase of property, plant and equipment was SGD 272,000 against SGD 957,000 last year. Addition to intangible assets was SGD 1,000.

For the quarter, the company reported property, plant & equipment written off of SGD 23,000 compared to SGD 39,000 a year ago.

For the year, barring unforeseen circumstances, the Directors expect the Group to continue operational growth for the rest of the year.